Applicable scenarios:This scale is for preliminary self-screening only and cannot replace professional clinical diagnosis. If results indicate high risk, consult a psychiatrist/psychologist for further evaluation.
Answer method:Recall daily performance over the past 6 months and rate each item on a 0-4 scale.
This questionnaire is adapted from the ASRS-v1.1/ASRS-5 scale (DSM-5 version) developed by the World Health Organization (WHO) in collaboration with Harvard University. It has been validated in numerous studies and shown to have good reliability and validity in Chinese populations. The test consists of two parts: Part A is a 6-question quick screening, and Part B is a complete 18-question assessment that provides a comprehensive understanding of attention and hyperactivity/impulsivity symptoms.